Hyperprolinaemia — Research Summary
Printed from RareWays (rareways.com.au) on 10 June 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Acquired Hyperprolinemia
Patricia E Fitzsimons et al. (1 January 2026)
https://doi.org/10.13140/rg.2.2.33383.92320
- 2.
Nutritional and Biochemical Aspects of Vitamin B6: Implications for Epilepsy and Health"
M. Tejasri et al. — Frontiers in Cell Science (25 November 2025)
https://doi.org/10.2174/0127726215397477251115033606
- 3.
Neurobiology of L-proline: From molecules to behavior.
Carvalho Gustavo Almeida et al. — Neuroscience (5 March 2025)
https://pubmed.ncbi.nlm.nih.gov/39826672/
- 4.
Unravelling neuroinflammation-mediated mitochondrial dysfunction in mild cognitive impairment: Insights from targeted metabolomics
R. Trivedi et al. — Brain Organoid and Systems Neuroscience Journal (16 October 2024)
https://doi.org/10.1016/j.bosn.2024.10.001
- 5.
L-proline determination by molecularly imprinted nanoparticles: A potential nanoscale tool for the diagnosis of metabolic disorders.
Nergiz Mustafa et al. — Journal of chromatography. A (16 August 2024)
https://pubmed.ncbi.nlm.nih.gov/38917678/
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Hyperprolinaemia
Hyperprolinaemia is a rare metabolic disorder in which the amino acid proline accumulates in the blood due to an enzyme deficiency. It occurs in two forms: type I (proline oxidase deficiency, usually benign) and type II (P5C dehydrogenase deficiency, associated with neurological symptoms and seizures). Research is ongoing into the neurological implications and long-term outcomes of both types.
Most Recent Research
Common Questions
What is Hyperprolinaemia?
Hyperprolinaemia is a rare metabolic disorder in which the amino acid proline accumulates in the blood due to an enzyme deficiency. It occurs in two forms: type I (proline oxidase deficiency, usually benign) and type II (P5C dehydrogenase deficiency, associated with neurological symptoms and seizures). Research is ongoing into the neurological implications and long-term outcomes of both types.
How many clinical trials are available for Hyperprolinaemia?
No clinical trials are currently indexed for Hyperprolinaemia. This may change as new trials are registered. Check back regularly or visit ClinicalTrials.gov directly.
Where does the research data for Hyperprolinaemia come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Hyperprolinaemia.
No spam. Unsubscribe any time. Not medical advice.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.